BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2427844)

  • 1. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol in angina pectoris: a controlled study.
    Eff J; Godfrey J; Garutti R; Capone P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S132-4. PubMed ID: 2427843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Celiprolol in the treatment of chronic stable angina].
    Román O; Cuevas G; Martínez D; Vargas W
    Rev Med Chil; 1991 Jan; 119(1):50-5. PubMed ID: 1688095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE; Eff J; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative study of celiprolol and nicardipine in stable angina of effort].
    Prohías Martínez JA; Chaple M; Rivero-Varona MM; Hernández-Acosta K; Toruncha-Chukram A; García-Barreto D
    Arch Inst Cardiol Mex; 1991; 61(4):345-9. PubMed ID: 1683217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
    Douard H; Koch M; Laporte T; Abella ML; Provendier O; Broustet JP
    Int J Cardiol; 1989 Oct; 25(1):63-8. PubMed ID: 2571590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S119-21. PubMed ID: 2427840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.